Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)

Guardado en:

Detalles Bibliográficos
Autores principales:	Shahneen Sandhu, Grant A McArthur, Kate Drummond, Alison Weppler, Tony Papenfuss, Amir Iravani, Belinda Lee, Richard J Young, Kortnye Smith, Peter Kar Han Lau, Breon Feran, Lorey Smith, Arian Lasocki, Ramyar Molania, Christopher Angel, Hanxian Aw Yeang, Ismael A Vergara, David Kok, Paul Joseph Neeson, Karen E Sheppard, Benjamin J Solomon
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/b420b6d4298340e19b198383efd6e211
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares